Moreover, mean NfL fragment plasma levels increased 3.4 times faster in subjects who developed AD compared to those who remained dementia-free in a trajectory analysis of 4444 non-demented participants in the Rotterdam study at baseline and up to 14 years follow-up. This evidence concerns the gene NEFL and dementia.